Olgers, T. J. http://orcid.org/0000-0002-5119-5245
Lieveld, A. W. E.
Kok, B.
Heijmans, J.
Salet, D.
Assman, N. L.
Postma, D. F.
Bauer, M. P.
Nanayakkara, P. W. B.
Meijer, K.
Bosch, F. H.
Kooistra, H.
Article History
Received: 29 March 2022
Accepted: 19 April 2022
First Online: 14 May 2022
Declarations
:
: KM reports speaker fees from Alexion, Bayer and CSL Behring, participation in trial steering committee for Bayer, consulting fees from Uniqure, participation in data monitoring and endpoint adjudication committee for Octapharma. This is all outside the submitted work. Fees are paid to her institution. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: The local Medical Ethics Review Committee of the University Medical Center Groningen (UMCG) reviewed the protocol and decided that a formal review of the study was not required according to Dutch law (UMCG Research Registry 202000263). Informed consent was obtained from all individual participants included in the study.